Article Text

Download PDFPDF

E-063 Percutaneous Bleomycin Sclerotherapy for Conjunctival Venous and Lymphatic Malformations
  1. A Berenstein
  1. Neurosurgery, Mount Sinai Health System, New York, NY


Purpose To describe the use of bleomycin in a foam preparation and or undiluted in slow flow vascular lesions that involve the conjunctiva as the sole treatment

Material and methods 5 patients with venous malformations, and 2 with lymphatic malformations involving the conjunctiva were treated with various combination bleomycin injections in to the lesion under direct puncture, using various needles and or angio-catheters; and monitored with US or DSA.

Results There was significant improvement, or near total resolution in all patients with a follow up of up to 3 years, there were no complications

Conclusions The use of bleomycin in various forms appears as a simple, safe and very effective treatment for low flow vascular lesions involving the conjunctiva, avoiding more elaborated and challenging surgical intervention.

Disclosures A. Berenstein: None.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.